BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
CXCL2
,
nitric oxide metabolic process
,
Influenza
,
Prostate
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FANCD2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bone marrow
Testes
Thymus gland
Tonsil
Subthalamic nucleus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Hematopoietic stem cells (HSC) and erythroblasts from Fancd2 knockout mice treated with oxymetholone
Embryonic kidney HEK293T cells with CRISPR-mediated RBBP8 knockout
Dermal fibroblasts overexpressing wildtype or mutant histone H3.1 or with EZH2 shRNA knockdown
Hematopoietic stem cells with induced double knockout of RUNX1 and RUNX3
Cervical cancer primary biopsies prospectively linked to cisplatin/radiation therapy response
Explore Curated Studies Results
Literature
Most Relevant Literature
Pan-cancer analysis of the tumorigenic role of Fanconi anemia complementation group D2 (FANCD2) in h…
FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-relate…
Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/FANCD2 axis in non-s…
FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.
FANCD2 knockdown with shRNA interference enhances the ionizing radiation sensitivity of nasopharynge…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR)…
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurre…
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damag…
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ